Akebia Therapeutics Inc (AKBA)
Cost of Revenue
$10.42M
Quarterly · Period ending: · USD
AKBA Cost of Revenue
Latest reported$10.42Mperiod ending
Latest reported$10.42Mperiod ending
AKBA Quarterly Cost of Revenue ($0.00 → $10.42M)
Quarterly cost of revenue
High-resolution chart · PNG
AKBA cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 10,424,000 | |
| 12,618,000 | |
| 12,217,000 | |
| 9,701,000 | |
| 9,919,000 | |
| 7,625,000 | |
| 20,365,000 | |
| 14,161,000 | |
| 8,298,000 | |
| 2,715,000 | |
| 18,665,000 | |
| 18,009,000 | |
| 17,284,000 | |
| 20,189,000 | |
| -3,095,000 | |
| 38,281,000 | |
| 18,600,000 | |
| 31,344,000 | |
| 31,723,000 | |
| 15,944,000 | |
| 52,495,000 | |
| 34,606,000 | |
| 26,823,000 | |
| 30,345,000 | |
| 174,616,000 | |
| 27,713,000 | |
| 10,032,000 | |
| 38,263,000 | |
| 37,669,000 | |
| 31,257,000 | |
| 7,685,000 | |
| 70,634,000 | |
| 71,917,000 | |
| 61,404,000 | |
| 68,382,000 | |
| 58,711,000 | |
| 43,751,000 | |
| 60,049,000 | |
| 33,435,000 | |
| 31,238,000 | |
| 30,877,000 | |
| 20,235,000 | |
| 43,016,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |